TIGIT and hepatocellular carcinoma: At the same time, we found that compared with HBV-LC patients, the expression of TIM3 on peripheral blood CD4+ T cells and TIGIT on CD8+ T cells in HBV-HCC patients increased, which was consistent with previous research results (35).